Sign up to save your podcasts
Or
Share Gramps Place - Medical Cannabis-Is The Research Only Anecdotal?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Gramps Place - Medical Cannabis-Is The Research Only Anecdotal?
This podcast will hopefully help you decide for yourself whether or not we have enough scientific and medical research that is more than 'anecdotal evidence,' and that we need to move forward with clinical studies and trials in many areas and for many conditions.
Listen as Gramps outlines several studies and trials that have already been completed. He interviews doctors, researchers and patients who all weigh in on the subject of medical cannabis, the research, and the catch 22 that is holding us up.
We have one obstacle. The obstacle is the fact what we call 'anecdotal evidence' in regard to cannabis is the exact same type of evidence that pharmaceutical companies have when they apply for permission for clinical trials for a product that they have developed. What keeps us from getting the trials for cannabis is the schedule 1 status. It's a catch 22 that needs to go away!
***OVER 30,000 PEOPLE HAVE ALREADY WATCHED THE DOCUMENTARY VERSION ON FaceBook & YouTube***
©2016-2021 Gramps Place Podcast
Music by: https://www.bensound.com
View all episodes
By Gramps - Chris Grisolia
5
11 ratings
This podcast will hopefully help you decide for yourself whether or not we have enough scientific and medical research that is more than 'anecdotal evidence,' and that we need to move forward with clinical studies and trials in many areas and for many conditions.
Listen as Gramps outlines several studies and trials that have already been completed. He interviews doctors, researchers and patients who all weigh in on the subject of medical cannabis, the research, and the catch 22 that is holding us up.
We have one obstacle. The obstacle is the fact what we call 'anecdotal evidence' in regard to cannabis is the exact same type of evidence that pharmaceutical companies have when they apply for permission for clinical trials for a product that they have developed. What keeps us from getting the trials for cannabis is the schedule 1 status. It's a catch 22 that needs to go away!
***OVER 30,000 PEOPLE HAVE ALREADY WATCHED THE DOCUMENTARY VERSION ON FaceBook & YouTube***
©2016-2021 Gramps Place Podcast
Music by: https://www.bensound.com